Published in Cancer Causes Control on November 01, 2016
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34
High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes Control (2002) 3.81
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07
Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol (2011) 3.01
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Selection of anthropometric indicators for classification of abdominal fatness--a critical review. Int J Obes Relat Metab Disord (1998) 2.17
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Obesity and cancer. Proc Nutr Soc (2008) 2.00
Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 1.75
Circulating adipokine levels and endometrial cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev (2013) 1.58
Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control (2007) 1.48
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies. BJOG (2015) 1.45
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev (2007) 1.39
Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev (2008) 1.30
The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women. Menopause (2010) 1.27
Body size and the risk of postmenopausal breast cancer subtypes in the California Teachers Study cohort. Cancer Causes Control (2012) 1.05
Long-term postmenopausal hormone therapy and endometrial cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.04
Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer. Int J Cancer (2011) 1.03
Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst (2015) 1.01
Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis. Am J Epidemiol (2013) 0.94
Trajectory of body shape across the lifespan and cancer risk. Int J Cancer (2016) 0.93
Body size across the life course and risk of premenopausal and postmenopausal breast cancer in Black women, the Carolina Breast Cancer Study, 1993-2001. Cancer Causes Control (2014) 0.91
Postmenopausal endometrial cancer risk and body size in early life and middle age: prospective cohort study. Br J Cancer (2012) 0.89
Menopausal hormone therapy and risk of endometrial cancer. J Steroid Biochem Mol Biol (2013) 0.89
Prospective study of body fat distribution and the risk of endometrial cancer. Cancer Epidemiol (2015) 0.83
Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. Int J Cancer (2015) 0.82
Body weight in early adulthood, adult weight gain, and risk of endometrial cancer in women not using postmenopausal hormones. Cancer Causes Control (2014) 0.80
Obesity and endometrial cancer: unanswered epidemiological questions. BJOG (2015) 0.78